Scott Requadt

-

Director Information, Funds, Firms

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Scott Requadt
Firm
Addressc/o Talaris Therapeutics, Inc 201 E Jefferson St, Suite 110B
Louisville, KY 40202
Source
Associated Funds Form D Role 2011 - 2026 Raised AUM
Talaris Therapeutics Inc 021-377389 Executive Officer
115.0 M
of 115.0 M
ESSA Pharma Inc 021-347780 Director
36.0 M
of 36.0 M
VBI Vaccines Inc/BC 021-327445 Director
7.0 M
of 7.0 M
AVROBIO Inc 021-304752 Director
60.5 M
of 61.0 M
VBI Vaccines Inc/BC 021-276702 Director
10.6 M
of 10.6 M
AVROBIO Inc 021-268222 Director
7.5 M
of 25.0 M
VBI Vaccines Inc/BC 021-266313 Director
13.6 M
of 13.6 M
ESSA Pharma Inc 021-260489 Director
5.0 M
of 5.0 M
ESSA Pharma Inc 021-255472 Director
15.0 M
of 15.0 M
Clarus Ventures III GP LP 021-225116 Executive Officer

of 50.0 M
TYRX Inc 021-196569 Director
2.0 M
of 2.0 M
TYRX Inc 021-189287 Director
2.0 M
of 2.1 M
TYRX Inc 021-173235 Director
2.5 M
of 5.2 M
TYRX Pharma Inc 021-151474 Director 23.1 M
of 25.2 M
TYRX Pharma Inc 021-68851 Director 11.0 M
of 11.0 M
Clarus Ventures LLC
Clarus IV-A LP 021-286937 Executive Officer
789.7 M
of 880.0 M
217.3 M
Clarus IV-B LP 021-286939 Executive Officer
789.7 M
of 880.0 M
139.5 M
Clarus IV-C LP 021-286940 Executive Officer
789.7 M
of 880.0 M
257.5 M
Clarus IV-D LP 021-286941 Executive Officer
789.7 M
of 880.0 M
51.4 M
Clarus Defined Exit I LP 021-222299 Executive Officer
100.0 M
of 100.0 M
63.9 M
Clarus de II LP 021-224951 Executive Officer
40.0 M
of 40.0 M
26.8 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com